Search

Your search keyword '"Cossiga, Valentina"' showing total 176 results

Search Constraints

Start Over You searched for: Author "Cossiga, Valentina" Remove constraint Author: "Cossiga, Valentina" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
176 results on '"Cossiga, Valentina"'

Search Results

1. Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study

2. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

3. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

4. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

5. THU-378 Prediction of outcomes in patients with HCV compensated liver cirrhosis after SVR: results from 5-years of follow-up

6. SAT-007-YI Assessing sex differences in access to liver transplantation in Italy: a real-world nationwide study

7. LBP-038 Expanding knowledge regarding real-world treatment of patients with primary biliary cholangitis with obeticholic acid from the Italian RECAPITULATE cohort

8. THU-093 Biochemical response and liver stiffness variation over time predict liver-related events in patients with primary biliary cholangitis treated with Obeticholic acid

9. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

11. Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients

14. Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study.

15. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

16. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort

19. Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort

21. Anti‐HDV reflex testing in HBsAg‐positive subjects: An efficacious strategy to identify HDV infection

22. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

23. Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort

24. Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage

25. COVID-19 and Fatty Liver Disorders

28. Implementation of anti-HDV reflex testing among HBsAg-positive in a tertiary center in South Italy

29. Predicting de‐novoportal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort

32. Anti‐HDV reflex testing in HBsAg‐positive subjects: An efficacious strategy to identify HDV infection.

33. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

35. Vascular liver diseases: A sex-oriented analysis of the literature

36. The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight

37. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

38. The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight.

39. Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents

41. Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients

42. De-novo occurrence of portal vein thrombosis in patients with HCV-related cirrhosis after sustained virological response: medium to long term observations from the ongoing PITER cohort

43. Humoral response to 2-dose BNT162b2 mRNA vaccine for COVID-19 in liver transplant recipients

46. Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study

48. Covid-19 in Liver Transplant Recipients: An Italian Case-Control Double-Centre Study.

49. Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD

50. Additional file 1 of Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort

Catalog

Books, media, physical & digital resources